Abstract
The communication network for adverse drug reaction data is discussed from the viewpoint of an international pharmaceutical company. Data collection within each country, subsequent transmission to company headquarters, and the processing which follows prior to final entry into the central data base are described, as well as the dissemination of final output data.
Get full access to this article
View all access options for this article.